Pmv Pharmaceuticals Correlations

PMVP Stock

USD 1.60 0.01 0.63%

The current 90-days correlation between Pmv Pharmaceuticals and Bright Minds Biosciences is 0.01 (i.e., Significant diversification). The correlation of Pmv Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Pmv Pharmaceuticals Correlation With Market

Significant diversification

The correlation between Pmv Pharmaceuticals and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pmv Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Pmv Stock, please use our How to Invest in Pmv Pharmaceuticals guide.

Moving together with Pmv Stock

0.64	LPTX	Leap Therapeutics	Pair Corr
0.68	NAMS	NewAmsterdam Pharma	Pair Corr
0.7	PLRX	Pliant Therapeutics	Pair Corr
0.63	AGIO	Agios Pharm	Pair Corr
0.83	SGMO	Sangamo Therapeutics Buyout Trend	Pair Corr
0.68	AVTE	Aerovate Therapeutics	Pair Corr
0.7	CRVS	Corvus Pharmaceuticals	Pair Corr
0.65	VREX	Varex Imaging Corp	Pair Corr

Moving against Pmv Stock

0.66	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.63	PEPG	PepGen	Pair Corr
0.54	NKTX	Nkarta Inc Buyout Trend	Pair Corr
0.5	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.47	FDMT	4D Molecular Therapeutics	Pair Corr
0.32	MNOV	MediciNova	Pair Corr
0.64	COLL	Collegium Pharmaceutical	Pair Corr
0.49	ACIU	AC Immune	Pair Corr
0.48	ANEB	Anebulo Pharmaceuticals	Pair Corr
0.44	ADAP	Adaptimmune Therapeutics	Pair Corr
0.43	BDTX	Black Diamond Therap	Pair Corr
0.36	SYBX	Synlogic	Pair Corr
0.36	TCBPW	TC BioPharm plc	Pair Corr

Related Correlations Analysis

	DRUG	HPQ	INTC	CVX	KO	TRV	JNJ	JPM	MSFT
DRUG		0.63	0.56	0.64	-0.8	0.81	-0.55	0.72	0.01	DRUG
HPQ	0.63		0.81	0.81	-0.64	0.65	-0.66	0.75	0.03	HPQ
INTC	0.56	0.81		0.81	-0.69	0.62	-0.81	0.65	0.22	INTC
CVX	0.64	0.81	0.81		-0.84	0.7	-0.86	0.87	-0.08	CVX
KO	-0.8	-0.64	-0.69	-0.84		-0.74	0.88	-0.86	0.09	KO
TRV	0.81	0.65	0.62	0.7	-0.74		-0.56	0.75	0.18	TRV
JNJ	-0.55	-0.66	-0.81	-0.86	0.88	-0.56		-0.75	0.04	JNJ
JPM	0.72	0.75	0.65	0.87	-0.86	0.75	-0.75		-0.13	JPM
MSFT	0.01	0.03	0.22	-0.08	0.09	0.18	0.04	-0.13		MSFT
	DRUG	HPQ	INTC	CVX	KO	TRV	JNJ	JPM	MSFT

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

JNJ	+ 0.88	KO
JPM	+ 0.87	CVX
TRV	+ 0.81	DRUG
INTC	+ 0.81	HPQ
CVX	+ 0.81	HPQ
CVX	+ 0.81	INTC

High negative correlations

JPM	- 0.86	KO
JNJ	- 0.86	CVX
KO	- 0.84	CVX
JNJ	- 0.81	INTC
KO	- 0.8	DRUG
JPM	- 0.75	JNJ

Risk-Adjusted Indicators

There is a big difference between Pmv Stock performing well and Pmv Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pmv Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
DRUG	49.12	28.18	2.88	(0.77)	4.62	(58.09)	9.23	(11.87)	1,471
HPQ	1.31	0.03	0.02	0.15	1.62	(1.30)	2.22	(2.63)	6.13
INTC	2.36	0.04	0.07	0.14	2.58	(2.68)	6.36	(3.50)	18.29
CVX	0.90	0.07	0.02	0.22	1.05	(0.93)	2.21	(1.79)	5.13
KO	0.68	(0.15)	0.00	(1.28)	0.00	0.00	1.11	(1.66)	4.00
TRV	1.08	0.15	0.11	0.27	1.17	(1.26)	1.93	(2.17)	11.31
JNJ	0.61	(0.10)	0.00	(0.37)	0.00	0.00	1.40	(1.42)	3.25
JPM	1.12	(0.01)	0.06	0.12	1.42	(1.19)	2.05	(2.00)	15.87
MSFT	0.90	(0.03)	(0.04)	0.07	1.49	(0.86)	2.09	(1.85)	8.19

Pmv Pharmaceuticals Corporate Management

Laura Leon	VP Operations	Profile
Leila MD	Chief Officer	Profile
Winston MBA	COO CFO	Profile
Marc MD	Senior Affairs	Profile
Tim Smith	Senior Relations	Profile
Robert Ticktin	Head Counsel	Profile
Deepika PharmD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC